KORU Medical Systems Inc (KRMD)
3.17
+0.09
(+2.92%)
USD |
NASDAQ |
Nov 15, 16:00
3.12
-0.05
(-1.58%)
After-Hours: 20:00
KORU Medical Systems Research and Development Expense (TTM): 5.191M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.191M |
| March 31, 2024 | 5.653M |
| December 31, 2023 | 5.742M |
| September 30, 2023 | 6.097M |
| June 30, 2023 | 5.666M |
| March 31, 2023 | 5.373M |
| December 31, 2022 | 4.956M |
| September 30, 2022 | 4.264M |
| June 30, 2022 | 4.202M |
| March 31, 2022 | 3.285M |
| December 31, 2021 | 2.474M |
| September 30, 2021 | 1.876M |
| June 30, 2021 | 1.466M |
| March 31, 2021 | 1.378M |
| December 31, 2020 | 1.297M |
| September 30, 2020 | 1.235M |
| June 30, 2020 | 1.014M |
| March 31, 2020 | 0.8945M |
| December 31, 2019 | 0.7405M |
| September 30, 2019 | 0.5308M |
| June 30, 2019 | 0.4875M |
| March 31, 2019 | 0.3332M |
| December 31, 2018 | 0.2411M |
| September 30, 2018 | 0.1756M |
| June 30, 2018 | 0.0735M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.1035M |
| September 30, 2017 | 0.1528M |
| June 30, 2017 | 0.2057M |
| February 28, 2017 | 0.2375M |
| November 30, 2016 | 0.2468M |
| August 31, 2016 | 0.2393M |
| May 31, 2016 | 0.2103M |
| February 29, 2016 | 0.2073M |
| November 30, 2015 | 0.2054M |
| August 31, 2015 | 0.2707M |
| May 31, 2015 | 0.3904M |
| February 28, 2015 | 0.4682M |
| November 30, 2014 | 0.4931M |
| August 31, 2014 | 0.4271M |
| May 31, 2014 | 0.3118M |
| February 28, 2014 | 0.2182M |
| November 30, 2013 | 0.1679M |
| August 31, 2013 | 0.1531M |
| May 31, 2013 | 0.147M |
| February 28, 2013 | 0.1476M |
| November 30, 2012 | 0.1525M |
| August 31, 2012 | 0.143M |
| May 31, 2012 | 0.116M |
| February 29, 2012 | 0.0903M |
| November 30, 2011 | 0.0588M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.7405M
Minimum
Dec 2019
6.097M
Maximum
Sep 2023
3.305M
Average
3.285M
Median
Mar 2022
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics Inc | 28.53M |
| Retractable Technologies Inc | 0.654M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 2.145M |
| Catheter Precision Inc | 0.219M |